"In a nutshell, the Ki-67 tumor analysis approaches were quite comparable, similar to our previous analysis with the Ki-67 30-9 clone4. These results also demonstrate a significant time benefit of using an AI-driven method for Ki-67 analysis in breast cancer, ensuring that Ki-67 services are delivered efficiently and effectively to …

“Part of my work as a scientist and pathologist is to rank, score, grade, count, or otherwise quantify visual features. Typically, this means evaluation of tissue sections using a microscope and identification of differences amongst treatment groups."